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Abstract
Circulation CD4
+CD25
+FoxP3
+ regulatory T cells (Tregs) have been associated with the delicate balancing between control
of overwhelming acute malaria infection and prevention of immune pathology due to disproportionate inflammatory
responses to erythrocytic stage of the parasite. While the role of Tregs has been well-documented in murine models and P.
falciparum infection, the phenotype and function of Tregs in P. vivax infection is still poorly characterized. In the current
study, we demonstrated that patients with acute P. vivax infection presented a significant augmentation of circulating Tregs
producing anti-inflammatory (IL-10 and TGF-b) as well as pro-inflammatory (IFN-c, IL-17) cytokines, which was further
positively correlated with parasite burden. Surface expression of GITR molecule and intracellular expression of CTLA-4 were
significantly upregulated in Tregs from infected donors, presenting also a positive association between either absolute
numbers of CD4
+CD25
+FoxP3
+GITR
+ or CD4
+CD25
+FoxP3
+CTLA-4
+ and parasite load. Finally, we demonstrate a suppressive
effect of Treg cells in specific T cell proliferative responses of P. vivax infected subjects after antigen stimulation with Pv-
AMA-1. Our findings indicate that malaria vivax infection lead to an increased number of activated Treg cells that are highly
associated with parasite load, which probably exert an important contribution to the modulation of immune responses
during P. vivax infection.
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Introduction
Malaria is a major worldwide scourge, infecting and killing
several millions of individuals each year [1]. Of the species that
infect humans, Plasmodium vivax and Plasmodium falciparum are the
two most important human malaria parasites. While deaths by P.
vivax are rare compared to the P. falciparum, there is an increasing
number of publications reporting severe disease, including
respiratory distress and coma as a result of P. vivax infection
[2,3]. Although the worldwide burden of P. vivax malaria has not
been reliably estimated, the annual infections may range from 132
million to 391 million people [4] and 2.6 billion people living in
areas of risk [5]. This disease affects poor people living in least
developed and developing countries. Infection by this parasite may
result in life-long learning impairment, incapacitating adults for
work, with major direct economic consequences due to loss of
productivity and depletion of the already meager financial
resources [6]. Despite the importance of this disease, representing
the most prevalent recurrent malaria [7], the immunological
mechanisms associated to the control of parasite levels and disease
severity are not fully understood.
Protective cellular immune responses against malaria can be
initiated by antigen-presenting cells (e.g. dendritic cells) that
ultimately activate specific CD4
+ and CD8
+ T cells. The resulting
protective Th1-dependent immune responses to blood-stage
malaria infection [8] is largely mediated by IFN-c and TNF-a
[9]. These cytokines act synergistically to optimize nitric oxide
production [10], which have been associated with parasite killing
[11]. Paradoxically, the morbidity of acute malaria is associated
with severe immune-mediated pathology due to disproportionate
inflammatory responses to the erythrocytic stage of the parasite
[12]. The delicate balancing between control of infection and
prevention of immunopathology [13] is attributed to
CD4
+CD25
+FoxP3
+ regulatory T cells (Tregs), which play an
important role in maintaining immune homeostasis and control-
ling excessive immune responses [14]. These cells have been
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9623shown to suppress cellular immune responses through direct
contact with immune effector cells and by the production of
regulatory cytokines, including TGF-b and IL-10 [15].
Evidences of the role of Treg cells as suppressors of T cell
responses in malaria were initially demonstrated in murine models,
where these cells have been associated with increased [16,17] or
delayed [18,19] parasite growth. Higher Treg cell numbers are
associated with increased parasite load [20–22] and development
of human infection caused by P. falciparum [23]. A functional deficit
of Treg cells, characterized by reduced expression of CTLA-4
(cytotoxic T lymphocyte antigen 4) and FoxP3 (forkhead box P3
transcription factor), was observed in studies involving the Fulani
ethnic group that present low susceptibility to clinical malaria by P.
falciparum [24].
While the role of Tregs in malaria infection has been well-
documented in murine models and P. falciparum infection, the
association of Treg cells and P. vivax infection is still poorly
understood. A recent study by Jangpatarapongsa and colleagues
[25] demonstrated an increase on the number of IL-10-producing
Treg cells in P. vivax-infected individuals. However, further
phenotypic and functional characterization of Tregs cells in vivax
malaria is still needed.
In the current study, we describe the augmentation of
circulating Treg cells in peripheral blood of P. vivax-infected
individuals and its possible association with parasite burden. We
also show the expression of molecules (CTLA-4 and glucocorti-
coid-induced tumor necrosis factor receptor - GITR) as well as
pro- and anti-inflammatory cytokines associated with suppression
by Tregs. Furthermore, the association between Treg subpopula-
tions and parasitemia was evaluated. We also demonstrated these
cells have a suppressive effect on in vitro T cell proliferative
responses of individuals infected with P. vivax. Our results point to
an increased numbers of activated Treg cells that are significantly
associated with parasite load and may exert their function by
modulating the immune responses during P. vivax infection.
Materials and Methods
Study Population and Blood Samples
Samples from 30 patients older than 18 years old with non-
complicated P. vivax malaria were used in the study. All patients
were resident in Manaus, the capital of the Amazonas State
(Western Brazilian Amazon). The patients were unrelated
outpatients being diagnosed at the Fundac ¸a ˜o de Medicina
Tropical do Amazonas. Fifteen healthy adult blood donors were
recruited for the study over the course of several months from Belo
Horizonte, Minas Gerais State, Brazil, a non-endemic area for
malaria. The study was approved by the Ethics Committee on
Research with Humans of Universidade Federal de Minas Gerais
(Protocol# ETIC 060/07). Blood was obtained after receiving the
signed inform consent.
Venous blood was collected immediately before the beginning
of the antimalarial treatment in EDTA and heparin-containing
tubes (4 and 32 mL, respectively) and was used to prepare thick
smears for microscopy, to extract parasite DNA and for PBMC
isolation. Parasitological evaluation was performed by examina-
tion of 200 fields at l.0006magnification under oil-immersion. All
slides were examined by at least two well-trained microscopists
from the Brazilian Ministry of Health. The P. vivax mono-infection
was confirmed by PCR as previously described [26]. Hemoglobin,
hematocrit (HCT) and platelet levels were measured using an
automated blood cell counter (ABX Pentra 90; Horiba Diagnos-
tics, Kyoto, Japan) (Table 1). Correlation between platelet counts
and the level of parasitemia and hemoglobin level and parasitemia
was determined for both infected and control donors (Figure S1A
and S1B, respectively).
Isolation of Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells (PBMCs) were obtained as
previously described [27]. Briefly, cells were isolated from
heparinized blood on a density gradient centrifugation (Histopa-
queH, Sigma Aldrich Co., USA) and were resuspended at a final
concentration of 1610
7 cell/mL in RPMI 1640 medium (Invitro-
gen Co., USA) supplemented with 2 mM of L-glutamine (Sigma),
5% heat-inactivated human AB serum (Sigma) and 6% Antibiotic-
Antimycotic solution (Invitrogen).
Cell Phenotyping by Flow Cytometry and Intracellular
Staining
PBMCs were stained using monoclonal antibodies to determine
the expression of T regulatory cell markers (CD4, CD25 and
FoxP3), and co-expression of GITR (glucocorticoid-induced
tumor necrosis factor receptor), CD152/CTLA-4 (Cytotoxic T-
Lymphocyte Antigen 4), IFN-c, IL-17, IL-10 and TGF-b.
Cells were incubated with 2 mL of undiluted monoclonal
antibodies (all from BD Pharmingen, USA) conjugated either
with fluorescein isothiocyanate (FITC), phycoerythrin (PE) or
allophycocyanin (APC) in the dark for 30 min at room
temperature. Intracellular staining for FoxP3, CTLA-4 and
cytokines was performed using the eBioscience fixation/permea-
bilization buffer kit following manufacturer’s instructions. After
incubation, PBMCs were washed twice with 2 mL of phosphate-
buffered saline containing 0.01% sodium azide followed by
fixation in 200 mL of fixative solution (10 g/L paraformaldehyde,
1% cacodylic acid, 6.65 g/L sodium chloride, 0.01% sodium
azide). Phenotypic analyses were performed using a Becton
Dickinson FACScalibur flow cytometer and the analysis was
performed using the CellQuest software (BD Biosciences, USA)
(Figure S2).
Recombinant Pv-AMA-1
The recombinant protein representing amino acids 43 to 487
of Pv-AMA-1 [28,29] was expressed in Escherichia coli
BL21(DE3) at 37uCf o r3hb ya d d i n g0 . 1m Mi s o p r o p y l - 1 -
thio-b-D-galactopyranoside (IPTG, Invitrogen), as previously
described [27]. Pv-AMA-1 antigen was tested to determine the
presence of Gram-negative bacterial endotoxin using a chro-
mogenic Limulus Amebocyte Lysate test (QCL-1000, Cambrex,
USA) according to the manufacturer’s instruction, and was
found to be a non significant source of endotoxins (levels lower
than detection limit of 5 EU/mL).
Table 1. Description of the study population by age and
hematological parameters (Mean 6 SD).
Individuals
Characteristics
Malaria-infected
+
(n=30)
Malaria-naı ¨ve
(n=15)
Age mean, years 37.6612.63 36.43611.96
Hemoglobin (g/dL) 12.861.6* 16.161.1
Platelets (cells/mm
3) 96,600645,300* 184,400620,300
Parasitemia (parasites/mL) 492063474 0
+P. vivax infection detected by parasitological smears and PCR.
*Statistically different from control group (P,0.0001).
doi:10.1371/journal.pone.0009623.t001
Treg in Vivax Malaria
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+CD25
+ T Cells on In Vitro
Cellular Proliferation to Pv-AMA-1
For the analysis of suppression activity, CFDA-SE labeled
PBMCs from P. vivax infected individuals that presented positive
proliferative responses for P. vivax AMA-1 antigen were co-
incubated with autologous CD4
+CD25
+ isolated cells. CFDA-
SE labeling of freshly isolated PBMCs (10
6 cells/mL in PBS/1%
BSA) was performed by incubation of 0.4 mMC F D A - S E
(Molecular Probes, USA) for 10 minutes at room temperature.
CD4
+CD25
+ lymphocytes (T regulatory cells) were purified
from PBMCs by magnetic bead separation using a Quad-
roMACS cell separator (Miltenyi Biotec, USA). CD4
+ T cells
(.97% purity) were purified by using a T cell isolation kit
(Miltenyi Biotec, USA), and CD4
+CD25
+ T cells were enriched
by a single-step positive selection using anti-CD25 microbeads
(Miltenyi Biotec). All microbead isolations followed the manu-
facturer’s instructions. The purified CD4
+CD25
+ Tr e g u l a t o r y
cells were incubated at different concentrations (1:2, 1:5 and
1:10 ratios) with autologous CFDA-SE-labeled PBMCs pulsed
with P. vivax AMA-1 (1 mg/well), for 96 hours at 37
oCa n d5 %
CO2 atmosphere.
The cell proliferative response of PBMCs co-incubated
with CD4
+CD25
+ T regulatory cells was assessed using a
Becton Dickinson FACScan flow cytometer. Data on 5610
4
lymphocytes were acquired and the analysis was performed
using the CellQuest software (BD Biosciences, USA). The
results are expressed as CFDA-SE proliferation ratio, calcu-
lated by the proliferative response observed in co-cultures of
Pv-AMA-1-stimulated PBMCs with CD4
+CD25
+ T cells over
Pv-AMA-1-stimulated PBMCs only. Additional controls using
antigen only or mitogen (PHA, Sigma, USA) were also
included. CFDA-SE labeling of freshly isolated PBMCs (10
6
cells/mL in PBS/1% BSA) was performed by incubation of
0.4 mM CFDA-SE (Molecular Probes, USA) for 10 minutes at
room temperature. Cells were washed and set up as described
above.
Statistical Analysis
The one-sample Kolmogorov-Smirnoff test was used to
determine whether variability followed a normal distribution
pattern. P values were determined by two-tailed Mann-Whitney U
test. Correlation analysis was performed using Spearman rank
correlation. A P value,0.05 was considered significant. All
statistics were carried out using Prism 5.0 for Windows (GraphPad
Software, Inc.) software.
Results
Regulatory T Cell Frequency Is Elevated in P. vivax
Infected Donors
Regulatory T cells were identified by flow cytometry as
CD3
+CD4
+ T cells expressing both CD25 and FoxP3 markers
(Figure 1A) and are reported as absolute numbers of cells per
mm
3. Our data clearly show that number of Treg cells was
significantly increased in P. vivax-infected subjects (medi-
an=256.2 cells/mm
3) when compared to malaria-naı ¨ve donors
(median=116.5 cells/mm
3) (P=0.0119, Figure 1B). Further
analysis show that frequency of Treg cells (demonstrated by
proportion of positive cells) were also elevated in P. vivax-infected
subjects (P=0.0009, Figure S3A). Although the difference of both
absolute number and proportion of CD4
+CD25
+FoxP3
+ cells
between infected and control donors, the level of expression of
FoxP3 was similar in both groups (P=0.0833, data not shown).
Since the increased absolute number of CD4
+CD25
+FoxP3
+ cells
would reflect a possible augmentation of total CD4
+ lymphocytes,
the number of total CD4
+ cells was also analyzed. No difference
in the absolute number of this lymphocyte population was
observed between malaria infected and naı ¨ve individuals (data
not shown).
Peripheral Blood CD4
+CD25
+FoxP3
+ Subpopulations Are
Also Augmented in P. vivax Infected Donors
Once observed the elevated number of Treg cells in the
peripheral blood of infected donors, we further characterized this
cell population by evaluating the expression of molecules and
cytokines associated with cell modulation. Surface expression of
the GITR molecule and intracellular expression of CTLA-4 and
cytokines were evaluated by flow cytometry. P. vivax-infected
individuals presented a significant increase of circulating GITR
+
(P=0.0119, Figure 2A) and CTLA-4
+ Treg cells (P=0.0026,
Figure 1. Flow cytometric analysis of regulatory T cells. (A)
CD25 and FoxP3 expression in gated CD4
+CD3
+ lympho-
cytes. Dot plot show a representative data of 35 donors examined.
(B) Absolute numbers of circulating CD4
+CD25
+FoxP3
+ regulatory T
cells in malaria-naı ¨ve and P. vivax-infected donors (n=15 and 20,
respectively). Absolute numbers (cells/mm
3)a r ei n d i c a t e do nY - a x i s
and lines represent median. Statistical differences were detected
using Mann-Whitney U test and are indicated on the graph with
significant P values.
doi:10.1371/journal.pone.0009623.g001
Treg in Vivax Malaria
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cytometric analysis also showed a significant increase on
CD4
+CD25
+FoxP3
+ T cells producing IFN-c (P,0.0001), IL-17
(P=0.0020), TGF-b (P,0.0001) and IL-10 (P,0.0001)
(Figures 2C to 2F) in malaria-infected individuals. Similar results
were observed when proportion of cells expressing CTLA-4
+,
TGF-b, IL-10, IFN-c, and IL-17 were analyzed (Figures S3C to
S3G, P,0.05 for all). No differences in the proportion of GITR
+
between infected and control individuals was observed
(P=0.3866, Figure S3B).
Figure 2. Flow cytometric analysis of surface markers (CTLA-4 and GITR) and cytokines (IFN-c, IL-17, TGF-b, and IL-10) in
CD4
+CD25
+FoxP3
+ regulatory T cells in malaria-naı ¨ve and P. vivax-infected donors (n=15 and 20, respectively). Results were expressed
as absolute numbers of cells expressing (A) GITR, (B) CTLA-4, (C) IFN-c, (D) IL-17, (E) TGF-b, and (F) IL-10. Absolute numbers (cells/mm
3) are indicated
on Y-axis and lines represent median. Statistical differences were detected using Mann-Whitney U test and are indicated on the graphs with
significant P values.
doi:10.1371/journal.pone.0009623.g002
Treg in Vivax Malaria
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Is Upregulated in CD4
+CD25
+FoxP3
+ Cells from P. vivax
Infected Donors
The expression of analyzed surface and intracellular markers
was determined by median intensity of fluorescence in order to
obtain the absolute expression level per cell basis. Following the
increase in the absolute numbers of Treg subpopulations, P.
vivax infected donors presented a significant higher expression
level of all markers tested (CTLA-4, GITR, TGF-b,I L - 1 0 ,I F N -
c and IL-17) on CD4
+CD25
+FoxP3
+ cells when compared to
those observed on malaria-naı ¨ve subjects (P,0.0001 for all,
Figure 3).
Absolute Number of Treg Cells Correlates with Parasite
Burden in P. vivax-Infected Individuals
The significantly higher absolute number of circulating
CD4
+CD25
+FoxP3
+ cells observed in parasitized donors
(Figure 1) suggested that this cell population may have an
important role during malaria infection. To further evaluate
whether there is a direct correlation between these two variables,
the absolute numbers of CD4
+CD25
+FoxP3
+ Treg cells were
correlated with the levels of parasitemia (Figure 4). The data
clearly shows that the number of peripheral Treg cells increases
with the level of parasitemia (Rs=0.48, P=0.0364) in P. vivax
infected individuals. Similar significant correlations were also
observed between parasitemia and absolute numbers of Treg
expressing GITR (Rs=0.66, P=0.0017), CTLA-4 (Rs=0.47,
P=0.0349), IFN-c (Rs=0.52, P=0.0187), TGF-b (Rs=0.66,
P=0.0016), IL-10 (Rs=0.59, P=0.0067) and IL-17 (Rs=0.68,
P=0.0011) (Figure 5). These data may imply a direct association
between increased parasite number, CTLA-4 and GITR expres-
sion and possibly cytokine production.
CD4
+CD25
+ Treg Cells Regulate Antigen-Specific PBMC
Proliferation in P. vivax-Infected Individuals
In order to determine the possible effect of Treg cells on the
immune response during malaria infection, a functional assay was
designed to evaluate whether CD4
+CD25
+FoxP3
+ Treg cells can
modulate the in vitro immune response to parasite antigen. When
isolated CD4
+CD25
+ T cells were added to the in vitro cultures
(independent of cell ratio) of Pv-AMA-1-stimulated PBMCs
obtained from two individuals (previously selected due to posi-
tive in vitro proliferative responses after antigen stimulation) a
significant reduction on the cell proliferative response elicited by
Figure 3. Expression of surface markers (CTLA-4 and GITR) and cytokines (IFN-c, IL-17, TGF-b, and IL-10) on CD4
+CD25
+FoxP3
+
regulatory T cells in malaria-naı ¨ve and P. vivax-infected donors (n=15 and 20, respectively). Results were expressed as median intensity
of fluorescence (lines represent median) for (A) GITR, (B) CTLA-4, (C) IFN-c, (D) IL-17, (E) TGF-b, and (F) IL-10 on CD4
+CD25
+FoxP3
+ cells. Statistical
differences were detected using Mann-Whitney U test and are indicated on the graphs with significant P values.
doi:10.1371/journal.pone.0009623.g003
Figure 4. CD4
+CD25
+FoxP3
+ regulatory T cells are directly
correlated with parasite burden. The relationship between
absolute numbers of CD4
+CD25
+FoxP3
+ regulatory T cells and degree
of parasitaemia among 20 patients with Plasmodium vivax malaria was
examined using Spearman rank correlation.
doi:10.1371/journal.pone.0009623.g004
Treg in Vivax Malaria
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These results suggest that these cells do have the capacity to
modulate the in vitro response at least to this P. vivax-specific
antigenic preparation. No significant differences were observed in
cultures stimulated with PHA for all tested individuals (data not
shown).
Discussion
CD4
+CD25
+FoxP3
+ T cells, also known as T regs, play an
important role maintaining immune homeostasis and controlling
excessive immune responses [14]. These cells suppress cellular
immune responses through direct contact with immune effector
cells and by production of regulatory cytokines, including TGF-b
and IL-10 [15]. Over the past four decades, since its first
description in the early 1970’s [30,31], several studies have focused
to describe the role of Tregs in infectious diseases (reviewed in
[15,32]), including tuberculosis [33], hepatitis C [34], leishman-
iasis [35,36], helminthiasis [37–40] and malaria [16–20,22,41–
44]. Although consistent evidence based on experimental models
and human P. falciparum infection suggest that Tregs may
contribute to the onset of infection, the role of these cells during
malaria and the possible mechanisms of regulation are not yet fully
elucidated. Furthermore, the association of Treg cells and P. vivax
infection is still poorly understood.
In the current study, we initially showed that P. vivax-naturally
infected individuals present a significant augmentation of
circulating Treg cells in peripheral blood, as previously
demonstrated in murine and P. falciparum infections
[20,41,42]. Of note, while absolute number and proportion of
CD4
+CD25
+FoxP3
+ cells is higher in malaria infected individ-
uals, no differences were observed for number/proportion of
CD4
+ lymphocytes. The expansion of Tregs in the above
settings has been significantly associated with increased or
delayed parasite growth [16–19] as well as with increased
parasite load [20–22] and development of clinical malaria [23].
Indeed, herein we also observe a positive correlation between
absolute numbers of Treg cells and parasite burden in P. vivax
malaria. Although the number of peripheral Treg cells increases
according to the level of parasitemia, the relationship between
number of parasites and host’s regulatory T cell activity is still
n o tc l e a r .H o w e v e r ,i ti sp o s s i b l et h a ti n c r e a s e dT r e ga c t i v i t y
may trigger modulation of host immune response and
consequently predisposes to parasite survival and/or failure in
the control of parasite multiplication. On the other hand,
increased Treg responses might also account for limitation of
exacerbated infection-induced pathology, which would be lately
beneficial to the host.
A variety of potential mediators of Treg activity that could
contribute to the suppression of the host’s immune response have
been identified, including GITR [45,46], CTLA-4 [47], FoxP3
[48,49], and the anti-inflammatory cytokines IL-10 and TGF-b
[50–52]. Our results show a significant increase of circulating
CD4
+CD25
+FoxP3
+GITR
+ and CD4
+CD25
+FoxP3
+CTLA-4
+
lymphocytes in P. vivax-infected donors, which was further
correlated with level of parasitemia observed in the same
individuals. Interestingly, a higher expression of these markers
on per cell basis was also seen in P. vivax-infected donors. Both
GITR and CTLA-4 molecules are constitutively expressed on cell
surface of natural Tregs [32] and are regulated by FoxP3
expression [53,54]. Initial studies related to the effects of GITR-
signaling on Treg cells indicated that interaction of this receptor
with agonist antibody or GITR ligand (GITRL) lead to an
apparent abrogation of suppressive activity of Tregs [45,46,55].
However, although not essential for the T cell suppressor activity
[54], the engagement of GITR promotes proliferation of Tregs
[54,56] and potential enhancement of their suppressive function
[55]. Nonetheless, the augmentation of circulating number of
CD4
+CD25
+FoxP3
+ co-expressing GITR in P. vivax infected
subjects might partially reflect the expansion of Tregs observed in
those individuals. In this context, we suggest that proliferation of
Treg cells in these individuals is elicited by GITR expression,
which is possibly upregulated by FoxP3 expression. Although the
effect of GITR signaling in Treg cells of P. vivax infected donors
Figure 5. Correlation of CD4
+CD25
+FoxP3
+ regulatory T cell co-expressing (A) GITR, (B) CTLA-4, (C) IFN-c, (D) TGF-b, (E) IL-10, and (F)
IL-17 and degree of parasitaemia among 20 patients with Plasmodium vivax malaria. Statistical significance was determined by Spearman
rank correlation.
doi:10.1371/journal.pone.0009623.g005
Treg in Vivax Malaria
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+CD25
+ T regulatory cells from P. vivax-infected individuals. (A) CFDA-SE Proliferation
ratio of Pv-AMA-1- stimulated PBMCs (sPBMCs) and sPBMCs co-cultured with different proportions of autologous CD4
+CD25
+ lymphocytes (1:2, 1:5
and 1:10, CD4
+CD25
+ cells: sPBMCs). Results are expressed for two malaria-infected donors who presented positive proliferative response after Pv-
AMA-1 stimulation. (B) Representative FACS histogram plots for 1 out 2 donors with positive proliferative response after Pv-AMA-1 stimulation
showing CFDA-SE staining after antigen stimulation and co-culturing with CD4
+CD25
+ T cells. CFDA-SE Proliferation ratio for sPBMCs was calculated
by proliferative response observed in Pv-AMA-1-stimulated PBMCs (indicated by positivity for CFDA-SE) divided by basal proliferative response of
non-stimulated cells (PBMCs only). CFDA-SE Proliferation ratio for co-cultured cells were calculated by proliferative response observed in Pv-AMA-1-
stimulated PBMCs with CD4
+CD25
+ T cells divided by proliferative response observed in Pv-AMA-1-stimulated PBMCs only.
doi:10.1371/journal.pone.0009623.g006
Treg in Vivax Malaria
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infection alter GITR signaling in Tregs, and this eventually
contributes to the escape of parasites from host T cell immunity
[57].
The inhibitory receptor CTLA-4 presents partial homology to
CD28 molecule and interacts to the same ligands, CD80 and
CD86, with a much higher affinity [58]. The suppressive effect of
CTLA-4 is associated with the reduced IL-2 production and IL-2
receptor expression, and by arresting T cells at the G1 phase of the
cell cycle [59,60]. Moreover, CTLA-4 expressing Treg cells induce
the expression of the enzyme indoleamine 2,3-dioxygenase (IDO)
by antigen-presenting cells which degrades tryptophan, and the
lack of this essential amino acid inhibits T cell activation and
promotes T cell apoptosis [61]. An indirect evidence of the role of
this receptor in experimental malaria has been demonstrated by
the in vivo blockade of CTLA-4 using specific monoclonal
antibody, leading to an exacerbation of P. berghei-mediated
immunopathology [19,62]. Although the potential functional role
of CTLA-4 in regulatory T cell activity remains controversial [63],
the increased number of CTLA-4
+ Treg cells in P. vivax-infected
donors suggests that regulation may occur through direct contact
between antigen-presenting cells and Tregs after engagement of
the CTLA-4 pathway. Moreover, since the number of CTLA-4
+
Tregs is positively associated with parasitemia, it may suggest the
involvement of this receptor on the outcome of human malaria. A
reduced expression of CTLA-4 was observed in the Fulani ethnic
group, contributing to their lower susceptibility to malaria
infection and suggesting that alterations in the maturation process
of Treg in Fulani individuals may also account for the generation
of a lower number of Treg [24].
In this study, patients with acute P. vivax infection presented
a significant augmentation of CD4
+CD25
+FoxP3
+ cells pro-
ducing the anti-inflammatory cytokines IL-10 and TGF-b,
which also correlated positively with parasite burden. Both
cytokines exert a critical role on the regulation of type-1
response in experimental malaria [21] and contribute to Treg
cell suppressive activity in vivo [64]. This regulatory activity
may limit the malaria-induced inflammation, therefore pre-
venting the severity of clinical malaria. However, although IL-
10 and TGF-b are naturally produced by Tregs [32] and are
required to induce FoxP3 expression [65], it is not clear
whether or how parasite replication might influence the
production of these cytokines. Conversely, we also observed
an increased number of circulating CD4
+CD25
+FoxP3
+ T cells
that produce IFN-c and IL-17 in peripheral blood of P. vivax-
infected donors, which also correlated with the levels of
parasitemia. Recently, Scholzen and colleagues [65] demon-
strated the intracellular production of IFN-c, IL-4 and IL-17,
by CD4
+CD25
+ Tregs with intermediate (also described as
e f f e c t o rTc e l l s )r a t h e rt h a nh i g he x p r e s s i o no fF o x P 3
molecule, suggesting the presence of different subsets of T
regulatory cells during malaria. In our study, however, we did
not observe any correlation between Foxp3 expression levels
and production of all intracellular cytokines assessed (data not
shown). Nevertheless, the role of these pro-inflammatory
c y t o k i n e si nm a l a r i a - e l i c i t e dT r e g ss t i l lr e m a i n st ob e
addressed.
Based in our results, we show that malaria-infected individ-
uals present an increased amount of activated Treg cells in the
peripheral blood, observed by increased numbers of Treg
subpopulations expressing cell surface molecules and mediators
associated with suppression of immune responses. Moreover, we
show that the same malaria-infected donors had an increased
expression of all markers tested. These results might partially
e x p l a i nt h er e d u c t i o no fa n t i g e n - s pecific proliferative responses
previously demonstrated in individuals infected with malaria
[66], and higher plasmatic IL-10 levels in acute P. vivax infection
[25]. Indeed, evidence from functional assays show that
augmentation of CD4
+CD25
+ Tc e l l sa b r o g a t e sa ntigen-specific
proliferation of PBMCs from infected individuals, suggesting the
role of Tregs during malaria infection. Of note, the ability of
Treg cells to abrogate P. falciparum-induced cell proliferation in
the Fulani population is directly associated to a reduced
expression of genes related to suppressive activity. Depletion
of Treg cells in Fulani individuals did not significantly increase
the proliferation of PBMCs in response to P. falciparum antigens,
whereas it restored an optimal response to the same antigens in
the sympatric highly susceptible Mossi population [24]. Finally,
we show that an increased number of circulating Tregs in acute
infected individuals is associated with parasite load. In fact,
regulatory T cells might limit infection-mediated pathology but
also compromise clearance of malaria-infected red blood cells
[21]. Whether the function of Tregs is beneficial to the host or
to parasite remains to be elucidated. Further studies are still
required to support the association of regulatory T cells and
immunosupression in a diverse P. vivax infection clinical
presentation.
Supporting Information
Figure S1 Correlation between hemoglobin levels (A) and
platelet counts (B) and the degree of parasitaemia among patients
with Plasmodium vivax malaria. Statistical significance was deter-
mined by Spearman rank correlation.
Found at: doi:10.1371/journal.pone.0009623.s001 (0.10 MB TIF)
Figure S2 FACS analysis. Representative FACS histogram plots
for 1 out 35 donors expressing (A) GITR, (B) CTLA-4, (C) IFN-c,
(D) IL-17, (E) TGF-b, and (F) IL-10 in CD4
+CD25
+FoxP3
+
regulatory T cells in malaria-naı ¨ve and P. vivax-infected donors.
CD4
+CD25
+FoxP3
+ cells were initially gated according to
Figure 1A. Histogram plots were used to determine the percentage
of positive cells and median intensity of fluorescence (MFI) for
each stain (M1 indicates positive population).
Found at: doi:10.1371/journal.pone.0009623.s002 (0.13 MB TIF)
Figure S3 Flow cytometric analysis of regulatory T cells
indicating proportion of total and subpopulations of Treg cells.
Results are expressed as percentage of positive cells for (A)
CD4
+CD25
+FoxP3
+, (B) CD4
+CD25
+FoxP3
+GITR
+, (C)
CD4
+CD25
+FoxP3
+CTLA-4
+, (D) CD4
+CD25
+FoxP3
+TGF-b
+,
(E) CD4
+CD25
+FoxP3
+IL-10
+, (F) CD4
+CD25
+FoxP3
+IFN-c
+,
and (G) CD4
+CD25
+FoxP3
+IL-17
+ in malaria-naı ¨ve and P. vivax-
infected donors (n=15 and 20, respectively). Proportions of
positive cells (%) are indicated on Y-axis and lines represent
median. Statistical differences were detected using Mann-Whitney
U test and are indicated on the graphs with significant P values.
Found at: doi:10.1371/journal.pone.0009623.s003 (0.21 MB TIF)
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